相关实验视频
Updated: Jan 18, 2026

12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
19.5K
KG-MACNF:一种非线性交叉模式融合模型,用于通过多关系嵌入和细粒度结构来预测药物向相互作用
Yihan Feng1, Xixin Yang1,2, Yuanlin Guan3
1College of Computer Science and Technology, Qingdao University, Qingdao, Shandong, China.
PloS one
|September 9, 2025
概括
这项研究引入了KG-MACNF,这是一种用于药物向相互作用 (DTI) 预测的新框架. 它通过使用先进的融合技术整合多式联网数据来提高准确性,改善药物发现.
科学领域:
- 生物信息学是一种生物信息学.
- 计算化学计算化学
- 药物发现 药物发现 药物发现
背景情况:
- 药物向相互作用 (DTI) 的预测对于药物开发和重新用途至关重要.
- 由于浅层融合策略,现有的多式联络模型难以捕捉生物网络中复杂的关系特征.
- 需要先进的方法来有效地整合各种数据模式,以便准确地预测DTI.
研究的目的:
- 提出一个新的框架,KG-MACNF,用于增强药物向相互作用预测.
- 解决当前DTI预测模型中捕获关系特征和多式联络数据融合方面的局限性.
- 提高DTI预测的准确性和稳定性,特别是在药物发现和重新利用方面.
主要方法:
- 利用知识图嵌入 (KGE) 来从生物网络中提取多层次的关系特征.
- 使用PoolGAT网络和CTD描述器来提取药物的结构和蛋白质序列特征.
- 开发了一个非线性驱动的交叉模式注意力融合网络,用于整合多式联网数据.
主要成果:
- 在Yamanishi_08和BioKG数据集上,KG-MACNF在DTI预测准确度方面显示出显著的优势.
- 该框架表现出强大的稳定性,特别是在不平衡的数据条件下.
- 在利用模式信息和功能互补方面成功克服了以前的瓶.
结论:
- KG-MACNF为药物发现和DTI预测提供了更准确和更强大的工具.
- 新的融合战略有效地整合了多式联运数据,优于现有方法.
- 该框架通过改进复杂的生物网络和分子数据的利用来推动该领域的发展.
相关概念视频
Drug-Receptor Bonds
4.2K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
4.2K
Combined Effects of Drugs: Synergism
6.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.8K
Drug-Receptor Interactions
7.3K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.3K
Quantitative Aspects of Drug-Receptor Interaction
1.7K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.7K
Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Targets for Drug Action: Overview
10.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.1K

